The p.R47H Variant of TREM2 Gene is Associated With Late-onset Alzheimer Disease in Colombian Population

Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):305-308. doi: 10.1097/WAD.0000000000000275.

Abstract

Objective: We evaluated the association of several single-nucleotide polymorphisms in the triggering receptor expressed on myeloid cells 2 (TREM2) gene in a Colombian sample of late-onset Alzheimer disease (LOAD).

Methods: The p.Q33* (rs104894002), p.R47H (rs75932628), p.R62H (rs143332484), and p.D87N (rs142232675) variants of TREM2 gene were directly genotyped using KASPar technology in 358 cases and 329 healthy controls. Sanger sequencing was used to validate >10% of KASPar's results. The Fisher exact test was used to compare the distribution of allelic and genotype frequency between cases and controls, and the Bonferroni correction was set at P<0.05.

Results: The minor allele frequency of rs75932628-T was 0.009 in cases and was not found in any healthy controls which suggests a significant association between rs75932628-T and LOAD risk in our sample (P=0.010). The rs143332484-T variant did not exhibit a significant association (P=0.160), whereas rs104894002 and rs142232675 were not found.

Conclusions: Our findings suggest that the rs75932628-T variant of TREM2 is an important risk factor for LOAD in the Colombian population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / genetics*
  • Colombia
  • Female
  • Genetic Predisposition to Disease*
  • Genetic Variation*
  • Genotype*
  • Humans
  • Male
  • Membrane Glycoproteins / genetics*
  • Polymorphism, Single Nucleotide
  • Receptors, Immunologic / genetics*
  • Risk Factors

Substances

  • Membrane Glycoproteins
  • Receptors, Immunologic
  • TREM2 protein, human